In three different species (i.e., mice, rats, and musk shrews), we show that glucose-dependent insulinotropic polypeptide receptor (GIPR) signaling blocks emesis and attenuates illness behaviors elicited by GLP-1R activation, while maintaining reduced food intake, body weight loss, and improved glucose tolerance
Liraglutides half-life is about 13 hours, so plasma levels are essentially cleared within 24-48 hours of the last injection
Its given weekly by injection and is often compared to GLP-1s because the effects (and side effects) overlap, but it tends to have stronger A1c reduction and weight loss effects
Many "side effects" resolve with adequate hydration alone
Research Your Destinations Medical Resources Its useful to know what resources are available at your destination in case of emergencies